Prof Kelly Cordoro (San Francisco, USA)

Session Chairs: Prof Lone Skov & Prof Eli Sprecher

Pediatric Psoriasis: Management Challenges and Opportunities

Dr. Kelly Cordoro is Professor of Dermatology and Pediatrics at the University of California, San Francisco and the McCalmont Family Endowed Professor in Pediatric Dermatology. She is Division Chief of Pediatric Dermatology and the Pediatric Dermatology Fellowship Director at UCSF. Dr. Cordoro’s clinical focus is inflammatory skin diseases in children. She is co-founder and co-director of the Pediatric Dermatology/Rheumatology Clinic at UCSF and a founding member of the Pediatric Dermatology Research Alliance. She Co-Chairs PeDRA’s Psoriasis Investigator Group. Her research program includes psoriasis, atopic dermatitis, melanoma, laser outcomes in children with disfiguring vascular anomalies, and the psychological impact of skin disease. She is a councilor on the International Psoriasis Council and serves on the Medical Board of the National Psoriasis Foundation. Dr. Cordoro is a passionate educator who has won several teaching awards. She currently serves as the Chair of the SPD Fellowship Directors Committee, Deputy Chair of the AAD Leadership Development Steering Committee and is the Wellness Champion within UCSF’s Dermatology Residency program.

Prof Inderjeet Dokal (London, United Kingdom)

Session Chairs: Prof. Dr. Peter Höger & Prof Alain Taïeb

Dyskeratosis congenital and related diseases

Inderjeet Dokal graduated in Medicine from the University of Leicester in 1983. He moved to Hammersmith Hospital (London) in 1984 where he received his post graduate clinical and research training. He was appointed Consultant in Paediatric Haematology in 1995 and was conferred the title of Professor of Haematology at Imperial College London in 2003. In 2006 he was recruited to the Chair of Child Health at Barts and The London School of Medicine and Dentistry, Queen Mary University of London. He is also an Honorary Consultant in Haematology (Barts Health) and Centre Lead for Genomics and Child Health. He has had a longstanding clinical and research interest in bone marrow failure syndromes such as dyskeratosis congenita. In 2010 he was elected Fellow of The Academy of Medical sciences.

Prof Alan Irvine (Dublin, Ireland)

Session Chairs: Dr Paula Beattie & Prof Larry Eichenfield

Alan is a Consultant Dermatologist in Children’s Health Ireland and St. James’s Hospital, Dublin, and Professor of Dermatology, Trinity College Dublin. He is a recognised and sought-after international expert in epithelial genetics, characterisation of the skin barrier, disease mechanisms in, and therapy of atopic dermatitis and allergy.

His international awards include the 2006 Times Higher Education Supplement Research Project of the Year and 2007 Paul Gerson Unna Prize (German Dermatology Society). He has delivered serval named/prize lectureships including the MB Sulzberger (AAD, 2018), Honig (CHOP/U Penn, 2018), RW Goltz (U Minnesota, 2016), Watson-Smith (RCP Edinburgh, 2015), Dolovich (AAAAI, 2013) Lectures. In 2015, Alan was made an inaugural director of the International Eczema Council, an international body of experts dedicated to the study and treatment of atopic dermatitis. In 2019 he was elected to the Royal Irish Academy.

Prof Amy Paller (Chicago, USA)

Session Chairs: Dr Paula Luna & Arti Nanda

Pathogenesis-based Therapy for Congenital Ichthyoses and Ichthyosiform Disorders: Beyond the Gene

Amy Paller, MS, MD is the Walter J. Hamlin Chair and Professor of Dermatology, Professor of Pediatrics, and Principal Investigator of the NIH-funded Skin Biology and Diseases Resource-based Center (SBDRC) at Northwestern University’s Feinberg School of Medicine. She received her undergraduate and graduate degrees from Brown University and her medical degree from Stanford University.  Dr. Paller completed residency training in both Pediatrics and Dermatology at Northwestern University and her postdoctoral research fellowship at the University of North Carolina. She served as Chief of Pediatric Dermatology at Northwestern’s Children’s Hospital until she became Chair of Dermatology in 2004. An author of more than 450 peer-reviewed publications, Dr. Paller is an NIH-funded investigator in both her laboratory-based and clinical research. She has directed the Pediatric Dermatology Clinical Trials Unit at Northwestern/ Lurie Children’s for the past 25 years and has been the lead investigator on several landmark trials in pediatric skin disease.  Her laboratory is currently focused on: a) inflammatory skin disorders and abnormal innervation; and b) topically delivered gene-suppressing nanotherapy for skin disorders. She has served the NIH on both NIAMS Council and its Board of Scientific Counselors, and currently serves on the NIH Advisory Committee on Research on Women’s Health. Dr. Paller has been President of the Society for Investigative Dermatology, the Society for Pediatric Dermatology, the Women’s Dermatologic Society, the Pediatric Dermatology Research Alliance, the International Eczema Council, and currently the International Society for Pediatric Dermatology. She has also served on the Board of Directors of the American Academy of Dermatology, the Society for Investigative Dermatology, the Society for Pediatric Dermatology, the Women’s Dermatologic Society, the American Dermatological Association, the International Society for Pediatric Dermatology and the International Eczema Council. She has co-edited several leading textbooks of dermatology, most notably Fitzpatrick’s Dermatology in General Medicine, and co-authors Hurwitz’s Clinical Pediatric Dermatology. She has been an Associate Editor of the Journal of Investigative Dermatology and has served on the editorial boards of several other journals. She has received numerous honors, among them the Stephen Rothman Award from the Society for Investigative Dermatology, Mentor of the Year, Rose Hirschler, and the Wilma Bergfeld, MD Visionary & Leadership awards from the Women’s Dermatological Society, the Clarence S. Livingood, MD Memorial Award from the AAD, the Founder’s Award from the Chicago Dermatological Society, and the inaugural Paula Stern Outstanding Women in Science and Medicine Award from Northwestern University. An avid advocate for patients with skin disease, Dr. Paller serves on numerous boards for dermatology patient advocacy organizations.

Prof Pierre Vabres (Dijon, France)

Session Chairs: Dr Jon Dyer & Dr Mary Glover

I Walk the Line

Pierre Vabres, MD, is Professor and Chair of Dermatology, Department of Dermatology – University Hospital, Dijon, France (since 2005). He holds his expertise in Pediatric Dermatology and Genodermatology, particularly in the diagnosis and innovative treatment of rare genodermatoses and skin development anomalies. He manages a national reference center for rare genetic skin diseases (MAGEC), specialized in skin mosaic syndromes

His research activity at INSERM unit UMR1231 focuses primarily on innovative translational and personalized approaches in dermatology. He coordinates a nationwide research project on identification of new genes involved in skin mosaic syndromes through whole genome and next generation sequencing, and clinical delineation and deep phenotyping of rare genetic skin conditions. He has been a principal investigator for clinical trials of drug repurposing in rare mosaic cutaneous and overgrowth syndromes such as the PIK3CA-related overgrowth spectrum. He is also involved in a multidisciplinary research project on the psychosocial impact of cosmetic disability related to congenital skin anomalies.

He has authored over 150 articles in peer-reviewed journals and has given numerous conferences as an invited speaker at international meetings of dermatology societies. He is a board member of the ESPD (European Society for Pediatric Dermatology) and SFDP (Société Française de Dermatologie Pédiatrique), member of the SPD (Society for Pediatric Dermatology). He is a member of the Editorial Board of Dermatology (Basel).